secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001104659-25-015647
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA abandons plan to acquire Poolbeg Pharma; issues Rule 2.8 no-offer statement
--------------------------------------------------------------------------------

- HOOKIPA board decides not to proceed with all-share acquisition of Poolbeg Pharma announced on Jan 2, 2025.
- Announcement made under UK Takeover Code Rule 2.8; HOOKIPA reserves right to reverse under certain conditions.
- Discussions for combination have ceased; no firm offer was made.
- Financial adviser Moelis & Company advised HOOKIPA on the potential deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925015647/0001104659-25-015647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925015647/tm257203d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-015647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer